ArticleNature genetics2018
Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution.
Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics.Blood cancer journal · 2020Trial
- A new cancer progression model: From synthetic tumors to real data and back.PLoS computational biology · 2026Article
- Statistical and Evolutionary Analysis of Sequenced DNA from Breast Cancer FFPE Specimens.bioRxiv : the preprint server for biology · 2025Article
- The balance between intrinsic and ecological fitness reveals hidden regimes in eco-evolutionary population dynamics.Research square · 2025Article
- The balance between intrinsic and ecological fitness reveals hidden regimes in eco-evolutionary population dynamics.bioRxiv : the preprint server for biology · 2025Article
- Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues.Cell genomics · 2023Article
- Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions.Nature communications · 2023Article
- Agent-based methods facilitate integrative science in cancer.Trends in cell biology · 2023Review
- Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma.Cancer discovery · 2022Article
- Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor.National science review · 2022Article
- Article
- Population genetics of clonally transmissible cancers.Nature ecology & evolution · 2022Review
- Gattaca: Base-Pair Resolution Mutation Tracking for Somatic Evolution Studies using Agent-based Models.Molecular biology and evolution · 2022Article
- Evolution under Spatially Heterogeneous Selection in Solid Tumors.Molecular biology and evolution · 2022Article
- Modes of Selection in Tumors as Reflected by Two Mathematical Models and Site Frequency Spectra.Frontiers in ecology and evolution · 2022Article
- Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.Diagnostics (Basel, Switzerland) · 2021Review
- Article
- Normal tissue architecture determines the evolutionary course of cancer.Nature communications · 2021Article
- Signatures of neutral evolution in exponentially growing tumors: A theoretical perspective.PLoS computational biology · 2021Article
- Neutral syndrome.Nature human behaviour · 2020Review
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.